Type 2 Diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who, after receiving a sufficient explanation, obtained written consent of their own free will after receiving sufficient explanations for participation in this study. 2. Patients who are 20 years of age or older at the time of obtaining consent 3. Type 2 diabetic patients who introduce SMBG through insulin treatment 4. Patients with SMBG measurement 5. Patients with exercise therapy 6. Patients with an HbA1c value of 7.0% or more but less than 10%
Exclusion criteria
Exclusion criteria: 1. Patients with an HbA1c value of less than 7.0% or more than 10% 2. Patients with neuropsychiatric disorders such as depression or alcoholism that appear to affect the evaluation of the trial 3. Patients with a malignant neoplasm 4. Patients with nephropathy stage 4 or more 5. Patients with restricted movement 6,Patients undergoing steroid therapy, anticancer drugs, interferon, or other treatments that affect blood sugar levels 7.Patients whose lead investigator or co-investigator determines that participation in the study is inappropriate from the viewpoint of the content of the study and safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Patient Satisfaction Survey 2.HbA1c Levels at Week 16 After Initiation of SMBG Coach Coaching Intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Correlation between SMBG's TIR and HbA1c 2.Changes in body weight (BMI), changes in muscle mass and fat mass due to inbody measurement, Blood pressure, biochemical examination | — |
Countries
Japan
Contacts
Fujita Health University School of Medicine Department of Endocrinology,Diabetes and Metabolism